Trends - drugmaker - Business Recorder

drugmaker

US FDA declines to approve Hutchmed’s China-tested cancer drug

WASHINGTON: Drugmaker Hutchmed Ltd said on Monday the US Food and Drug Administration has declined to approve its...

Published 03 May, 2022 03:47am

World

Japan orders 150 million doses of Novavax Covid vaccine

The cost of the deal was not announced, and it is contingent on the vaccine being approved in Japan

Published 07 Sep, 2021 11:41am

World

Health Canada recommends people with rare blood condition not get AstraZeneca vaccine

Until June 11, one case of capillary leak syndrome following vaccination with AstraZeneca's vaccine has been reported in Canada, Health Canada said

Published 30 Jun, 2021 10:35am

World

Germany expects faster Moderna COVID-19 vaccine deliveries

Moderna will increase its deliveries to 1.33 million doses a week in July from 733,000 previously expected, raising the figure to 2.57 million a week in August and 2.95 million a week in September, the ministry said.

Published 27 Jun, 2021 03:39pm

Business & Finance

Lilly to seek accelerated FDA approval for Alzheimer's drug this year

The FDA granted donanemab a breakthrough therapy designation, meant to expedite the development and review of medicines for serious or life-threatening conditions.

Published 24 Jun, 2021 04:36pm

Business & Finance

AstraZeneca commits to 1.8mn Thai vaccine doses amid supply anxiety

The joint announcement by AstraZeneca and Siam Bioscience, a firm owned by Thailand's king, comes amid public anxiety about vaccine supplies, as the country suffers its most severe outbreak so far.
It did not say whether the Thai plant would make all 6 million doses that Thailand's government has promised would be available this month.

Published 02 Jun, 2021 06:55pm

Business & Finance

Abbott cuts 2021 profit forecast on lower COVID-19 testing demand

"This has been driven by several factors, including significant reductions in cases in the US and other major developed countries, accelerated rollout of COVID-19 vaccines globally and, most recently, US health authority guidance on testing for fully vaccinated individuals," the drugmaker said.
Abbott sees second-quarter adjusted profit from continuing operations of at least $1 per share, compared with analysts' estimates of $1.23 per share.

Published 01 Jun, 2021 06:51pm

World

Pfizer raises 2021 sales forecast for Covid vaccines to $26bn

NEW YORK: Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher...

Updated 10 May, 2021 10:20am

Business & Finance

Eli Lilly profit forecast trimmed as vaccines dent US demand for COVID-19 drugs

Nearly 30% of the US population has been vaccinated against COVID-19, hitting demand for antibody drugs that already suffered from slower-than-expected uptake by hospitals.
Sales of other high-profile Lilly drugs also fell short of Wall Street expectations and its shares fell 3% to $181.64 in morning trading.

Published 27 Apr, 2021 08:23pm

World

EU to get 50m Pfizer doses early as Denmark scraps AZ

BRUSSELS: The EU said Wednesday it would get 50 million Pfizer vaccine doses earlier than expected, as rival...

Published 15 Apr, 2021 03:22am

Markets

Tuesday’s early trade: S&P, Nasdaq move up

NEW YORK: The S&P 500 and the Nasdaq rose on Tuesday as investors flocked to the perceived safety of...

Published 14 Apr, 2021 03:21am

World

U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca

The Department of Health and Human Services facilitated the move, the health official said in an email, asking not to be named due to the sensitivity of the matter.

Published 05 Apr, 2021 08:18am

World

US puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca

The top US infectious disease doctor told Reuters on Thursday the country may not need AstraZeneca's vaccine even if it wins approval.

Updated 04 Apr, 2021 05:49pm

World

AstraZeneca US trials thrown into doubt after promising data

Brazil's health ministry registered a record 3,251 fatalities in 24 hours, bringing the country's overall death toll to nearly 299,000 -- second only to the United States.

Published 24 Mar, 2021 11:14am

World

How AstraZeneca's errors eroded US confidence in its Covid shot

The Washington Post meanwhile reported that independent experts tasked with overseeing the trial had earlier written a letter to AstraZeneca.

Published 24 Mar, 2021 10:45am

World

AstraZeneca US trials thrown into doubt after promising data

WASHINGTON: A US health agency raised concerns Tuesday that AstraZeneca may have included out-of-date information...

Published 24 Mar, 2021 05:10am

Business & Finance

Moderna taps Baxter to support fill and finish of 60-90mn COVID-19 vaccine doses

Moderna's two-shot vaccine is one of the three COVID-19 vaccines authorized for emergency use in the United States along with Pfizer/BioNTech and Johnson & Johnson's.
Under the pact with Baxter, the fill and finish of Moderna COVID-19 vaccine will take place at the sterile manufacturing facilities located in Bloomington, Indiana, the companies said.

Updated 08 Mar, 2021 10:16pm

Business & Finance

Canada approves J&J's one-dose COVID-19 vaccine

The official announcement will be made later on Friday, said the source, who requested anonymity given the sensitivity of the situation.
If the J&J vaccine has been approved, it could ease some logistical challenges. The vaccine is administered in a single dose and can be stored in normal fridges while the Pfizer-BioNTech and Moderna shots must be kept in freezers.

Published 05 Mar, 2021 08:28pm

Business & Finance

Amgen pushes into Asia oncology market with $1.9bn Five Prime buy

The deal comes as Amgen looks to expand in the oncology market in Asia-Pacific region, where gastric cancer is more prevalent.
It gained a toehold in China in 2019 through a 20.5% stake in Chinese cancer drugmaker BeiGene Ltd for nearly $3 billion.

Updated 04 Mar, 2021 09:52pm

Business & Finance

Takeda buys epilepsy treatment rights from Ovid for up to $856mn

Takeda will be responsible for future development and commercialization of the drug, soticlestat, worldwide and Ovid will no longer have any financial obligation, the companies said.
The companies in August reported results from a mid-stage study showing soticlestat met the main goal of reduction in seizure frequency.

Published 03 Mar, 2021 07:01pm

Business & Finance

Merck to help make Johnson & Johnson's COVID-19 vaccine

After scrapping development of its own COVID-19 vaccine candidates in January, Merck last month said it was working on a deal to open up its manufacturing capacity to other vaccine makers.
J&J is shipping about four million doses of its vaccine in the United States this week, but the next shipments hinge on when its new, larger manufacturing plant receives regulatory approvals.

Published 02 Mar, 2021 08:34pm

Business & Finance

US to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy

The US government will have the option to purchase up to an additional 1.1 million doses through Nov. 25, the company said.
United States had already agreed to buy 1.45 million doses of bamlanivimab alone, Lilly said.

Published 26 Feb, 2021 06:33pm

World

Pfizer to ship 13mn COVID-19 vaccine doses per week to US by mid-March, says executive

The remarks put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans, and 700 million doses by mid-year.

Published 23 Feb, 2021 11:18am

Business & Finance

Czechs in talks with AstraZeneca for vaccines outside EU deal: report

Citing a Health Ministry spokeswoman, the report said the Anglo-Swedish drugmaker had offered the country further deliveries of its vaccine.
The European Commission, the European Union's executive, has signed supply deals with vaccine makers for doses to be distributed on a pro-rata basis to members states.

Published 13 Feb, 2021 05:51pm

Business & Finance

Roche's tocilizumab cuts deaths in hospitalised COVID-19 patients: study

The findings - from the RECOVERY trial, which has been testing a range of potential treatments for COVID-19 since March 2020.
We now know that the benefits of tocilizumab extend to all COVID patients with low oxygen levels and significant inflammation.

Published 11 Feb, 2021 09:05pm

World

Not perfect, but saves lives, AstraZeneca says as Africa backs COVID-19 shot

To double supplies to 200 mln a month by April.
To report US trial results by end March.
Forecasts 2021 core EPS of $4.75 to $5.00.
Q4 sales beat expectations, profit in line.
African Union says will use shot in countries without SA variant.

Published 11 Feb, 2021 08:15pm

Business & Finance

Teva Pharm Q4 profit tops estimates, sees mostly flat 2021

The world's largest generic drugmaker earned 68 cents per diluted share excluding one-time items in the October-December period, up from 62 cents a share a year earlier.
Analysts had forecast Teva would earn 63 cents a share ex-items on revenue of $4.37 billion.

Published 10 Feb, 2021 05:57pm

Business & Finance

Lilly says CFO resigns after investigation into inappropriate relationship

The drugmaker said it immediately hired external counsel to conduct an independent probe after it was made aware of the allegations.
Lilly said the behavior exhibited poor judgment by Smiley. The company would not give further details on the communications or the number of employees involved.

Updated 09 Feb, 2021 11:32pm

World

Pfizer withdraws application for emergency use of its COVID-19 vaccine in India

Indian health officials say they generally ask for so-called bridging trials to determine if a vaccine is safe and generates an immune response in its citizens whose genetic makeup can be different from people in Western nations.

Published 05 Feb, 2021 11:01am

World

J&J files COVID-19 vaccine application with U.S. FDA

The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report in which it said the vaccine had a 66% rate of preventing infections in its large global trial.

Published 05 Feb, 2021 09:52am

Gainers
Losers
Leaders

Stock	Price
786 Invest Ltd / Jun 25 786 Investments Limited(786)	4.99 ▼ 0.00 (0.00%)
AL-Abbas Sugar / Jun 25 Al-Abbas Sugar Mills Limited(AABS)	269.86 ▼ 0.00 (0.00%)
Agro Allianz / Jun 25 Agro Allianz Limited(AAL)	16.00 ▼ 0.00 (0.00%)
AL-Abid Silk / Jun 25 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Jun 25 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Jun 25 Allied Bank Limited(ABL)	68.99 ▼ 0.00 (0.00%)
Abbott Lab. / Jun 25 Abbott Laboratories (Pakistan) Limited(ABOT)	637.11 ▼ 0.00 (0.00%)
Abson Ind. / Jun 25 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / Jun 25 Alfalah Consumer Index ETF.(ACIETF)	7.70 ▼ 0.00 (0.00%)
Attock Cement / Jun 25 Attock Cement Pakistan Limited(ACPL)	69.85 ▼ 0.00 (0.00%)

Stock	Price
786 Invest Ltd / Jun 25 786 Investments Limited(786)	4.99 ▼ 0.00 (0.00%)
AL-Abbas Sugar / Jun 25 Al-Abbas Sugar Mills Limited(AABS)	269.86 ▼ 0.00 (0.00%)
Agro Allianz / Jun 25 Agro Allianz Limited(AAL)	16.00 ▼ 0.00 (0.00%)
AL-Abid Silk / Jun 25 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Jun 25 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Jun 25 Allied Bank Limited(ABL)	68.99 ▼ 0.00 (0.00%)
Abbott Lab. / Jun 25 Abbott Laboratories (Pakistan) Limited(ABOT)	637.11 ▼ 0.00 (0.00%)
Abson Ind. / Jun 25 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / Jun 25 Alfalah Consumer Index ETF.(ACIETF)	7.70 ▼ 0.00 (0.00%)
Attock Cement / Jun 25 Attock Cement Pakistan Limited(ACPL)	69.85 ▼ 0.00 (0.00%)

Stock	Volume

Markets →

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Jun 24	207.70
USD PKR Interbank Buying / Jun 24	207.50
USD to Japanese Yen / Jun 24	135.23
USD to Swiss Franc / Jun 24	0.96
Pound Sterling to USD / Jun 24	1.23
Euro to USD / Jun 24	1.06
UK LIBOR % / Jun 24	1.57

Stock	Volume
S&P 500 / Jun 24	3911.74
India Sensex / Jun 24	52727.98
Tokyo Nikkei / Jun 24	26491.97
Nasdaq / Jun 24	11607.62
Hang Seng / Jun 24	21719.06
FTSE 100 / Jun 24	7208.81
Dow Jones / Jun 24	31500.68
Germany DAX 30 / Jun 24	13118.13
France CAC40 / Jun 24	6073.35

Item	Value
Crude Oil USD/Barrel / Jun 24	107.62
Karachi Cotton PKR/37.32 KG / Jun 24	21180.00
Gold 10 Grams PKR / Jun 24	122300.00
Gold Spot USD/Ounce / Jun 24	1826.88
Cotton US¢/pound / Jun 24	98.05

drugmaker

Most Popular Articles